The local microenvironment shapes tumor progression through interactions among the implanted cancer material, surrounding tissue, blood vessels, stromal cells, and immune components. These site-specific relationships can influence how the tumor develops within its native organ context. Consequently, the model can reveal biological behavior that may be less apparent when tumor material grows outside the corresponding anatomical site.
An orthotopic model preserves the relationship between tumor material and the tissue where that cancer naturally originates, whereas an ectopic model places it elsewhere. This anatomical distinction can affect tissue-specific invasion, metastatic behavior, and responses to treatment. Comparing the two approaches helps researchers determine how strongly local tissue context contributes to observed cancer phenotypes and therapeutic outcomes.
Researchers may establish the model with tumor cells, tissue fragments, or patient-derived material. These starting materials provide different ways to study tumor development while retaining interactions with the matching tissue environment. Selecting among them allows cancer studies to focus on questions involving tumor biology, treatment response, drug delivery, imaging, or patient-specific therapeutic strategies, when appropriate material is available.
A typical workflow begins by selecting tumor cells, a tissue fragment, or patient-derived material that corresponds to the cancer of interest. The material is then implanted into the matching anatomical site so it can develop within the relevant organ environment. Researchers subsequently examine tumor progression and related outcomes, such as invasion, metastasis, imaging features, or treatment response.
This approach is useful when treatment performance may depend on the tumor’s native tissue environment. Because the model incorporates local blood vessels, stromal cells, immune components, and surrounding tissue, it can support evaluation of therapeutic efficacy and drug delivery. Researchers can also use it to examine whether treatment responses observed in a relevant anatomical setting differ from those in ectopic systems.
Patient-derived material can be implanted into the corresponding anatomical site to create a model connected to an individual cancer source. Such models support investigation of tumor progression, treatment responses, and drug delivery in a tissue-relevant setting. In cancer research, this makes orthotopic systems useful for exploring personalized treatment strategies alongside broader studies of tumor biology and therapeutic efficacy.